Hemoxygenase-1 Promotes Head and Neck Cancer Cell Viability

• Main Authors: Marilina Mascaró (Author), Exequiel G. Alonso (Author), Karen Schweitzer (Author), Martín E. Rabassa (Author), Jessica A. Carballido (Author), Agustina Ibarra (Author), Eliana N. Alonso (Author), Vicente Bermúdez (Author), Lucía Fernández Chavez (Author), Georgina P. Coló (Author), María Julia Ferronato (Author), Pamela Pichel (Author), Sergio Recio (Author), Valentina Clemente (Author), Maria Eugenia Fermento (Author), María Marta Facchinetti (Author), Alejandro C. Curino (Author)
• Format: Book
• Published: MDPI AG, 2022-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Head and neck squamous cell carcinoma (HNSCC) is a remarkably heterogeneous disease with around 50% mortality, a fact that has prompted researchers to try new approaches to improve patient survival. Hemoxygenase-1 (HO-1) is the rate-limiting step for heme degradation into carbon monoxide, free iron...